Mangoceuticals, Inc. (MGRX)
Nasdaq: MGRX · Services-Misc Health & Allied Services, NEC · Dallas, TX · filing with the SEC since 2022
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Apr 1, 2026 | Mar 20, 2025 | Apr 1, 2024 | · |
| Revenue | 456,021 | 615,873 | 731,493 | 8,939 |
| Cost of revenue | 54,422 | 93,296 | 154,900 | 4,089 |
| Gross profit | 250,386 | 379,964 | 431,501 | 4,850 |
| General and administrative | 3,756,373 | 3,000,571 | 3,319,417 | 1,643,572 |
| Total operating expenses | 18,282,735 | 8,351,957 | 9,650,391 | 1,996,432 |
| Operating income | -18,032,349 | -7,971,993 | -9,218,890 | -1,991,582 |
| Interest expense | 103,513 | 13,700 | -6,473 | 6,473 |
| Total non-operating income (expense) | -2,611,106 | -735,233 | 6,473 | -6,473 |
| Income before income taxes | -20,643,455 | -8,707,226 | -9,212,417 | -1,998,055 |
| Net income including non-controlling interests | -20,643,455 | -8,707,226 | -9,212,417 | · |
| Net income to non-controlling interests | -461 | -1,081 | · | · |
| Net income | -20,642,994 | -8,706,145 | -9,212,417 | -1,998,055 |
| Net income to common shareholders | -21,818,994 | -9,508,254 | · | · |
| Earnings per share, basic | -2.17 | -4.80r | -8.58r | -2.85b |
| Earnings per share, diluted | -2.17 | -4.80r | -8.58r | -2.85b |
| Weighted average shares, basic | 10,071,609 | 1,978,966 | 1,074,202r | 719,872b |
| Weighted average shares, diluted | 10,071,609 | 1,978,966 | 1,074,202r | 719,872b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding